Corporate Structure for missional investors – B Corp
In a very real sense, LifeBridge 10000’s service to its customers will be providing survival. The advanced cancer therapies being developed are expensive. Most of our efforts will be in offering therapies that have been proven safe and effective in one area (FDA approved) and have demonstrated effectiveness in preclinical studies in additional areas. However, the additional use of the therapies are years away, sometimes a decade or more from qualifying for third-party reimbursement by insurance companies.
For hundreds of thousands of late-stage cancer patients who’s disease is reoccurring and non-responsive to existing treatments, this is too late. Many will die in 12 to 18 months, while a possible therapy to extend their life is trapped in regulatory pipelines.
For this terminally ill class of patients, some countries allow special access or do not interfere with a doctor’s right to try a reasonable treatment. The United States now has 30 states that have “Right to Try” laws to give dying patients a chance to try therapies that are in the FDA pipeline, but are years away from approval and third-party reimbursement.
TTF is a prime example of a treatment that can benefit patients under these new laws. In preclinical studies, TTF has been shown to be effective in treating more than 20 types of cancer. There have been encouraging pilot studies involving Breast Cancer, Pancreatic Cancer and phase 1 and 2 trials for Non-Small Cell Lung Cancer (NSCLC). Millions of dollars are being spent on active next-phase clinical trials to show that TTF is effective in treating Mesothelioma, Pancreatic Cancer, Ovarian Cancer, NSCLC, and Metastatic Cancer to the brain.
Legally, terminally ill cancer patients can gain access to this promising treatment if companies are willing to supply them. However, patients must pay out-of-pocket for the treatment. To that end, LifeBridge 10000, LLC is set up contractually as a Benefit Corporation. The company is committed to making outstanding profits for its shareholders, but requires each to give away a percentage of their profits to patients who cannot afford treatment.
LifeBridge's corporate team not only believes this is the right thing to do, but also that it is good business and responsible citizenship. Therefore, LifeBridge 10000, LLC is only seeking missional investors willing to join us in the B-corp structure